{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:54:24Z","timestamp":1793498064461,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"DFG German Research Foundation","award":["TRR 205"],"award-info":[{"award-number":["TRR 205"]}]},{"name":"Else-Kr\u00f6ner-Fresenius-Stiftung"},{"name":"Eva-Luise-und-Horst-K\u00f6hler Stiftung"},{"name":"Bavarian Cancer Research Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adrenocortical carcinoma (ACC) is a rare but aggressive malignancy with a heterogeneous prognosis. To date, there are no reliable circulating biomarker to predict clinical outcomes in ACC. Agouti-related peptide (AgRP), an orexigenic hypothalamic neuropeptide, is also produced by the adrenal gland. However, its expression in adrenal tumours remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate AgRP levels in tissue and plasma of patients with ACC, benign adrenal tumours (BAT), and other malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>AgRP mRNA expression was assessed in silico, and protein levels were analysed by immunohistochemistry in ACC and BAT. Plasma AgRP (pAgRP) was measured using ELISA in patients with ACC, BAT, and other cancers. Tumour burden of ACC was quantified using RECIST1.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AgRP mRNA levels were higher in ACC than in BAT (3.0 vs 2.4, P &amp;lt; .0001). AgRP tissue expression was higher in ACC compared to BAT (H-score 120 [49] vs 80 [48], P &amp;lt; .0001). pAgRP was more elevated in ACC than BAT and other malignancies (1.3 vs 0.3 vs 0.2\u2005ng\/mL, all P &amp;lt; .0001) and was higher in ACC with high tumour burden than those with low and those ACC-free after surgery (2.7 vs 0.6 vs 0.3\u2005ng\/mL, P &amp;lt; .0001). pAgRP increased with the number of metastatic sites (\u22654 sites: 2.7\u2005ng\/mL vs 2-3: 1.5\u2005ng\/mL vs 1: 0.5\u2005ng\/mL, P &amp;lt; .05). In multivariable Cox regression, elevated pAgRP was independently associated with worse progression-free (HR = 2.654) and overall survival (HR = 2.624) (both P &amp;lt; .05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AgRP is more highly expressed in both tissue and plasma of ACC compared to BAT and other cancers. Its strong association with tumour burden and prognosis highlights its potential as biomarker in ACC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf226","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:13:30Z","timestamp":1761830010000},"page":"604-612","source":"Crossref","is-referenced-by-count":6,"title":["Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-5575","authenticated-orcid":false,"given":"Mario","family":"Detomas","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R","family":"Kagan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F H","family":"Pittaway","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P","family":"Schauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4610-0888","authenticated-orcid":false,"given":"Simon","family":"Kloock","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Geiger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-7861","authenticated-orcid":false,"given":"Otilia","family":"Kimpel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":false,"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]},{"name":"Comprehensive Cancer Center Mainfranken, University of W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-3249","authenticated-orcid":false,"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]},{"name":"Bavarian Cancer Research Center (BZKF), University Hospital of W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Dischinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology & Diabetes, University Hospital W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"11","key":"2025111722564614400_lvaf226-B1","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in The Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"2025111722564614400_lvaf226-B2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025111722564614400_lvaf226-B3","doi-asserted-by":"publisher","first-page":"101434","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-generation therapies for adrenocortical carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"14","key":"2025111722564614400_lvaf226-B4","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.3390\/cells11142234","article-title":"MicroRNAs and long non-coding RNAs in adrenocortical carcinoma","volume":"11","author":"Detomas","year":"2022","journal-title":"Cells"},{"issue":"1","key":"2025111722564614400_lvaf226-B5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"3","key":"2025111722564614400_lvaf226-B6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025111722564614400_lvaf226-B7","doi-asserted-by":"publisher","first-page":"698862","DOI":"10.3389\/fendo.2021.698862","article-title":"Circulating Fascin 1 as a promising prognostic marker in adrenocortical cancer","volume":"12","author":"Cantini","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2025111722564614400_lvaf226-B8","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.18632\/oncotarget.14067","article-title":"Livin\/BIRC7 expression as malignancy marker in adrenocortical tumors","volume":"8","author":"Altieri","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"2025111722564614400_lvaf226-B9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1530\/ERC-17-0095","article-title":"Topoisomerase 2alpha and thymidylate synthase expression in adrenocortical cancer","volume":"24","author":"Roca","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2025111722564614400_lvaf226-B10","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025111722564614400_lvaf226-B11","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1210\/jc.2017-00984","article-title":"Assessment of VAV2 expression refines prognostic prediction in adrenocortical carcinoma","volume":"102","author":"Sbiera","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025111722564614400_lvaf226-B12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/cac2.70012","article-title":"Dlk1 is a novel adrenocortical stem\/progenitor cell marker that predicts malignancy in adrenocortical carcinoma","volume":"45","author":"Mariniello","year":"2025","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"2025111722564614400_lvaf226-B13","doi-asserted-by":"publisher","first-page":"R271","DOI":"10.1530\/ERC-21-0208","article-title":"The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer","volume":"28","author":"Pittaway","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2025111722564614400_lvaf226-B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnins.2013.00019","article-title":"Unraveling the central proopiomelanocortin neural circuits","volume":"7","author":"Mercer","year":"2013","journal-title":"Front Neurosci"},{"issue":"8-12","key":"2025111722564614400_lvaf226-B15","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.2741\/2366","article-title":"The central melanocortin system and the regulation of energy balance","volume":"12","author":"Lee","year":"2007","journal-title":"Front Biosci"},{"issue":"8","key":"2025111722564614400_lvaf226-B16","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1210\/en.2016-1268","article-title":"AgRP-expressing adrenal chromaffin cells are involved in the sympathetic response to fasting","volume":"158","author":"Gupta","year":"2017","journal-title":"Endocrinology"},{"key":"2025111722564614400_lvaf226-B17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mce.2006.12.025","article-title":"Role of Agouti-related protein in adrenal steroidogenesis","volume":"265-266","author":"Doghman","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"2025111722564614400_lvaf226-B18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1046\/j.1365-2826.2000.00543.x","article-title":"Agouti related protein in the rat adrenal Cortex: implications for novel autocrine mechanisms modulating the actions of pro-opiomelanocortin peptides","volume":"12","author":"Bicknell","year":"2000","journal-title":"J Neuroendocrinol."},{"issue":"4","key":"2025111722564614400_lvaf226-B19","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1210\/en.2015-1430","article-title":"AgRP neuron-specific deletion of glucocorticoid receptor leads to increased energy expenditure and decreased body weight in female mice on a high-fat diet","volume":"157","author":"Shibata","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"2025111722564614400_lvaf226-B20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/jc.2018-01909","article-title":"Plasma agouti-related protein and cortisol levels in cushing disease: evidence for the regulation of agouti-related protein by glucocorticoids in humans","volume":"104","author":"Page-Wilson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025111722564614400_lvaf226-B21","doi-asserted-by":"publisher","first-page":"E1838","DOI":"10.1210\/jc.2014-1448","article-title":"Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome","volume":"99","author":"Page-Wilson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025111722564614400_lvaf226-B22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1055\/s-2005-872895","article-title":"Agouti related protein (AgRP) is upregulated in Cushing's syndrome","volume":"113","author":"Dhillo","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"2025111722564614400_lvaf226-B23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"issue":"2","key":"2025111722564614400_lvaf226-B24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2025111722564614400_lvaf226-B25","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1002\/ctm2.1798","article-title":"Single-nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoural adrenal glands","volume":"14","author":"Altieri","year":"2024","journal-title":"Clin Transl Med"},{"issue":"2","key":"2025111722564614400_lvaf226-B26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"2025111722564614400_lvaf226-B27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0090-4295(02)02163-5","article-title":"Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma","volume":"61","author":"Han","year":"2003","journal-title":"Urology"},{"issue":"13","key":"2025111722564614400_lvaf226-B28","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1002\/cncr.24333","article-title":"Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases","volume":"115","author":"Oh","year":"2009","journal-title":"Cancer"},{"key":"2025111722564614400_lvaf226-B29","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.2147\/CMAR.S203037","article-title":"Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer","volume":"11","author":"Yin","year":"2019","journal-title":"Cancer Manag Res"},{"key":"2025111722564614400_lvaf226-B30","doi-asserted-by":"publisher","first-page":"100724","DOI":"10.1016\/j.ctro.2024.100724","article-title":"Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: implications for the oligometastatic spectrum theory","volume":"45","author":"Christ","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"2025111722564614400_lvaf226-B31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0006-8993(02)03674-0","article-title":"Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats","volume":"958","author":"Savontaus","year":"2002","journal-title":"Brain Res"},{"issue":"1","key":"2025111722564614400_lvaf226-B32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.peptides.2009.09.036","article-title":"Glucocorticoids increase NPY gene expression in the arcuate nucleus by inhibiting mTOR signaling in rat hypothalamic organotypic cultures","volume":"31","author":"Shimizu","year":"2010","journal-title":"Peptides"},{"issue":"1","key":"2025111722564614400_lvaf226-B33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0006-291X(02)02991-1","article-title":"Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland","volume":"301","author":"Dhillo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2025111722564614400_lvaf226-B34","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025111722564614400_lvaf226-B35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4021\/wjon385w","article-title":"Circulating levels of agouti-related peptide in endometrial cancer survivors","volume":"2","author":"Bienertova-Vasku","year":"2011","journal-title":"World J Oncol"},{"key":"2025111722564614400_lvaf226-B36","doi-asserted-by":"publisher","first-page":"368075","DOI":"10.1155\/2012\/368075","article-title":"111In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis","volume":"2012","author":"Jiang","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"8","key":"2025111722564614400_lvaf226-B37","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1111\/febs.16176","article-title":"AgRP neurons: regulators of feeding, energy expenditure, and behavior","volume":"289","author":"Deem","year":"2022","journal-title":"FEBS J"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf226\/65050666\/lvaf226.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/604\/65050666\/lvaf226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/604\/65050666\/lvaf226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:56:52Z","timestamp":1763438212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/5\/604\/8307569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf226","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,30]]}}}